News Releases

Bolsters MSD Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries Complements MSD Animal Health’s broad portfolio of veterinary pharmaceuticals, vaccines and technology solutions RAHWAY, N.J., Feb. 5, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., […]

Read more

BRAVECTO rapidly and consistently kills Ixodes scapularis ticks, a vector of the pathogen responsible for Lyme Disease, as compared to Simparica TRIO® RAHWAY, N.J., February 2, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the publication of a recent study demonstrating BRAVECTO® (fluralaner) Chews for […]

Read more

Rahway, NJ, January  24, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it will showcase its portfolio of innovative solutions to advance the poultry industry as well as offer future talent development opportunities at the International Production and Processing Expo (IPPE) in Atlanta, GA from […]

Read more

Winning veterinary student set to investigate canine distemper virus maternal antibody transfer in dogs Rahway, NJ, January 23, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced the 2023 recipient of the World Small Animal Veterinary Association (WSAVA) Michael J. Day Scholarship, Lotta Truyen. A veterinary […]

Read more

More veterinary professionals are provided access to and are pursuing mental health resources for their overall wellbeing with continued improvements on the horizon RAHWAY, N.J., Jan. 15, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today released findings of its comprehensive Veterinary Wellbeing Study conducted in collaboration […]

Read more

Rahway, NJ, December 11, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK), today announced that the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. The CVMP recommends the product […]

Read more

First EU-licensed vaccine proven to protect against Cryptosporidium parvum in calves from birth onwards Rahway, N.J., Nov. 29, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that the European Commission has approved BOVILIS CRYPTIUM®, the first EU-licensed vaccine to protect cattle against Cryptosporidium parvum (C. parvum) […]

Read more

First cattle maternal vaccine effectively proven to protect against Cryptosporidium parvum in calves from birth onwards RAHWAY, N.J.,– Oct. 5, 2023 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the European Medicines Agency’s Committee for Veterinary Medicinal Products (CVMP) issued a positive opinion for BOVILIS CRYPTIUM®, […]

Read more